Next Hydrogen Solutions Inc. Announces Results of Annual General and Special Meeting of Shareholders
MISSISSAUGA, Ontario, June 06, 2024 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen“) (TSXV:NXH, OTC:NXHSF), a […]
Aben Minerals Mobilizes Crew and Equipment for Geophysical Survey at Justin Gold Project
Vancouver, BC, June 06, 2024 (GLOBE NEWSWIRE) — Aben Minerals Ltd. (TSX-V: ABM) (OTCQB: ABNAF) (Frankfurt: R26) (“Aben” or “the Company”) is pleased to […]
Abacus Acquires 100% of the Willow Porphyry Copper Property
VANCOUVER, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) — Abacus Mining & Exploration Corporation (“Abacus” or “The Company”) (TSXV:AME) is […]
ScottsMiracle-Gro updates fiscal ’24 guidance at peak of lawn and garden season
Reaffirms two-year free cash flow target of $1 billion, debt paydown of $350 million in fiscal ’24 and full-year non-GAAP […]
Mesa Provides Update on RASPRO Surplus CRJ Asset Transactions
PHOENIX, June 06, 2024 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today provided an update that […]
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
WAYNE, Pa., June 06, 2024 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing […]
Redecan Cannabis Introduces New Top Shelf Flower ‘Purple Churro’
TORONTO, June 06, 2024 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer […]
ABM Reports Second Quarter Fiscal 2024 Results and Raises Outlook for Fiscal Year 2024 Adjusted EPS
Revenue up 2% to $2.0 billion, all organic growth Net income of $43.8 million and GAAP EPS of $0.69, declines […]
Madison Metals Terminates Sanmiguel Agreement
TORONTO, June 06, 2024 (GLOBE NEWSWIRE) — Madison Metals Inc. (“Madison” or the “Company”) (CSE: GREN) (OTCQB: MMTLF) (FSE: 4EF0) […]
U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract
As part of Pluri’s previously announced $4.2 million 3-year contract with the U.S. National Institute of Allergy and Infectious Diseases […]
